Clinical trials have many moving parts and clinical supplies need to be prepared well in advance of the actual study start. This along with complex study protocols, variable and unpredictable patient recruitment, and limited storage space add to the challenge. Learn how efficient clinical supply management and forecasting can identify supply solutions that minimize or even potentially avoid supply chain disruptions.
Global regulatory standards for clinical trials are, simply put, complex. In this case study, learn how one company worked with its partner to overcome the challenge of a protocol based in the U.S., an investigational medical product (IMP) approved in the EU, and varying QP (qualified person) rules from country to country, to conduct their clinical trial in Israel.
Clinical supply models need to provide for an adequate supply of patient kits that allow for variations in patient recruitment levels and clinical site activity. Traditional, or supply-led models, address this challenge by creating large quantities of finished patient kits upfront in order to create a cushion of static inventory to manage uneven demand. However, this cushion comes at a cost.
Catalent in-house pharmaceutical sourcing specialists utilize a global network of leading manufacturers, wholesalers, and carefully selected QA-qualified healthcare professionals to provide cost-effective access to virtually any product. When you use Catalent for pharmaceutical sourcing you get a global distribution network that can deliver what you need, where you need it, and when you need it. Always in the right condition.